Overview
Saskia Imhof practices in Utrecht, Netherlands. Ms. Imhof is rated as an Experienced expert by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Her top areas of expertise are Pseudoxanthoma Elasticum, Keratoconus, Cataract, Corneal Transplant, and Cataract Removal.
Her clinical research consists of co-authoring 72 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 7 articles in the study of Age-Related Macular Degeneration (ARMD).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- KeratoconusMs. Imhof isDistinguished. Learn about Keratoconus.
- Pseudoxanthoma ElasticumMs. Imhof isDistinguished. Learn about Pseudoxanthoma Elasticum.
- Advanced
- CataractMs. Imhof isAdvanced. Learn about Cataract.
- Corneal TransplantMs. Imhof isAdvanced. Learn about Corneal Transplant.
- Experienced
- Age-Related Macular Degeneration (ARMD)
- Brain TumorMs. Imhof isExperienced. Learn about Brain Tumor.
- Cataract RemovalMs. Imhof isExperienced. Learn about Cataract Removal.
- Fuchs DystrophyMs. Imhof isExperienced. Learn about Fuchs Dystrophy.
- Increased Intracranial PressureMs. Imhof isExperienced. Learn about Increased Intracranial Pressure.
- Late-Onset Retinal DegenerationMs. Imhof isExperienced. Learn about Late-Onset Retinal Degeneration.